Clinical Trial Update: A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating combination therapy of Growth Hormone and GnRH agonist in children with idiopathic short stature.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)
• Growth Hormone (somatropin)

Snippet

Sponsor: Belgian Study Group for Pediatric Endocrinology | Conditions: Idiopathic Short Stature | Phase 4 | Status: UNKNOWN